EphrinB3 is an anti-apoptotic ligand that inhibits the dependence receptor functions of EphA4 receptors during adult neurogenesis

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1793, Issue 2, 2009, Pages 231-238

  Furne, Céline ^a   Ricard, Jerome ^b   Cabrera, Jorge Ruben ^a   Pays, Laurent ^a   Bethea, John R ^b   Mehlen, Patrick ^a   Liebl, Daniel J ^b  

^a CENTRE LÉON BÉRARD   (France)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Apoptosis; Dependence receptor; Eph receptor; Ephrin

Indexed keywords

CASPASE; CASPASE 3; CASPASE INHIBITOR; EPHRIN B3; EPHRIN RECEPTOR A4;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COUNT; CELL DEATH; HUMAN; HUMAN CELL; LATERAL BRAIN VENTRICLE; MALE; MOUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROBLAST; NONHUMAN; PRIORITY JOURNAL; SUBVENTRICULAR ZONE;

ANIMALS; APOPTOSIS; CASPASE 3; CELL LINE; CEREBRAL VENTRICLES; ENZYME ACTIVATION; EPHRIN-B3; HUMANS; LIGANDS; MALE; MICE; NEUROGENESIS; PHOSPHORYLATION; RECEPTOR, EPHA4; STEM CELLS; SUBSTRATE SPECIFICITY;

EID: 58549109596     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.09.009     Document Type: Article

References (34)

1. Pasquale E.B. Eph receptor signalling casts a wide net on cell behaviour. Nat. Rev., Mol. Cell Biol. 6 (2005) 462-475
2. Conover J.C., Doetsch F., Garcia-Verdugo J.M., Gale N.W., Yancopoulos G.D., and Alvarez-Buylla A. Disruption of Eph/ephrin signaling affects migration and proliferation in the adult subventricular zone. Nat. Neurosci. 3 (2000) 1091-1097
3. Holmberg J., Armulik A., Senti K.A., Edoff K., Spalding K., Momma S., Cassidy R., Flanagan J.G., and Frisen J. Ephrin-A2 reverse signaling negatively regulates neural progenitor proliferation and neurogenesis. Genes Dev. 19 (2005) 462-471
4. Ricard J., Salinas J., Garcia L., and Liebl D.J. EphrinB3 regulates cell proliferation and survival in adult neurogenesis. Mol. Cell. Neurosci. 31 (2006) 713-722
5. Aoki M., Yamashita T., and Tohyama M. EphA receptors direct the differentiation of mammalian neural precursor cells through a mitogen-activated protein kinase-dependent pathway. J. Biol. Chem. 279 (2004) 32643-32650
6. Depaepe V., Suarez-Gonzalez N., Dufour A., Passante L., Gorski J.A., Jones K.R., Ledent C., and Vanderhaeghen P. Ephrin signalling controls brain size by regulating apoptosis of neural progenitors. Nature 435 (2005) 1244-1250
7. Bredesen D.E., Mehlen P., and Rabizadeh S. Apoptosis and dependence receptors: a molecular basis for cellular addiction. Physiol. Rev. 84 (2004) 411-430
8. Matsunaga E., Tauszig-Delamasure S., Monnier P.P., Mueller B.K., Strittmatter S.M., Mehlen P., and Chedotal A. RGM and its receptor neogenin regulate neuronal survival. Nat. Cell Biol. 6 (2004) 749-755
9. Tauszig-Delamasure S., Yu L.Y., Cabrera J.R., Bouzas-Rodriguez J., Mermet-Bouvier C., Guix C., Bordeaux M.C., Arumae U., and Mehlen P. The TrkC receptor induces apoptosis: when the dependence receptor notion meets the neurotrophin paradigm. Proc. Natl. Acad. Sci. U. S. A. 104 (2007) 13361-13366
10. Tulasne D., Deheuninck J., Lourenco F.C., Lamballe F., Ji Z., Leroy C., Puchois E., Moumen A., Maina F., Mehlen P., and Fafeur V. Proapoptotic function of the MET tyrosine kinase receptor through caspase cleavage. Mol. Cell. Biol. 24 (2004) 10328-10339
11. Mehlen P., and Bredesen D.E. The dependence receptor hypothesis. Apoptosis 9 (2004) 37-49
12. del Rio G., Kane D.J., Ball K.D., and Bredesen D.E. A novel motif identified in dependence receptors. PLoS ONE 2 (2007) e463
13. Mehlen P., Rabizadeh S., Snipas S.J., Assa-Munt N., Salvesen G.S., and Bredesen D.E. The DCC gene product induces apoptosis by a mechanism requiring receptor proteolysis. Nature 395 (1998) 801-804
14. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., Houtzager V.M., Nordstrom P.A., Roy S., Vaillancourt J.P., Chapman K.T., and Nicholson D.W. A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272 (1997) 17907-17911
15. Thibert C., Teillet M.A., Lapointe F., Mazelin L., Le Douarin N.M., and Mehlen P. Inhibition of neuroepithelial patched-induced apoptosis by sonic hedgehog. Science 301 (2003) 843-846
16. Hubbard S.R. Juxtamembrane autoinhibition in receptor tyrosine kinases. Nat. Rev., Mol. Cell Biol. 5 (2004) 464-471
17. Binns K.L., Taylor P.P., Sicheri F., Pawson T., and Holland S.J. Phosphorylation of tyrosine residues in the kinase domain and juxtamembrane region regulates the biological and catalytic activities of Eph receptors. Mol. Cell. Biol. 20 (2000) 4791-4805
18. Wybenga-Groot L.E., Baskin B., Ong S.H., Tong J., Pawson T., and Sicheri F. Structural basis for autoinhibition of the Ephb2 receptor tyrosine kinase by the unphosphorylated juxtamembrane region. Cell 106 (2001) 745-757
19. Wang J.J., Rabizadeh S., Tasinato A., Sperandio S., Ye X., Green M., Assa-Munt N., Spencer D., and Bredesen D.E. Dimerization-dependent block of the proapoptotic effect of p75(NTR). J. Neurosci. Res. 60 (2000) 587-593
20. Mazelin L., Bernet A., Bonod-Bidaud C., Pays L., Arnaud S., Gespach C., Bredesen D.E., Scoazec J.Y., and Mehlen P. Netrin-1 controls colorectal tumorigenesis by regulating apoptosis. Nature 431 (2004) 80-84
21. Dohn M., Jiang J., and Chen X. Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis. Oncogene 20 (2001) 6503-6515
22. Fox B.P., and Kandpal R.P. Invasiveness of breast carcinoma cells and transcript profile: Eph receptors and ephrin ligands as molecular markers of potential diagnostic and prognostic application. Biochem. Biophys. Res. Commun. 318 (2004) 882-892
23. Hafner C., Schmitz G., Meyer S., Bataille F., Hau P., Langmann T., Dietmaier W., Landthaler M., and Vogt T. Differential gene expression of Eph receptors and ephrins in benign human tissues and cancers. Clin. Chem. 50 (2004) 490-499
24. Easty D.J., Mitchell P.J., Patel K., Florenes V.A., Spritz R.A., and Bennett D.C. Loss of expression of receptor tyrosine kinase family genes PTK7 and SEK in metastatic melanoma. Int. J. Cancer 71 (1997) 1061-1065
25. Mehlen P., and Puisieux A. Metastasis: a question of life or death. Nat. Rev. Cancer 6 (2006) 449-458
26. Batlle E., Bacani J., Begthel H., Jonkheer S., Gregorieff A., van de Born M., Malats N., Sancho E., Boon E., Pawson T., Gallinger S., Pals S., and Clevers H. EphB receptor activity suppresses colorectal cancer progression. Nature 435 (2005) 1126-1130
27. Guo D.L., Zhang J., Yuen S.T., Tsui W.Y., Chan A.S., Ho C., Ji J., Leung S.Y., and Chen X. Reduced expression of EphB2 that parallels invasion and metastasis in colorectal tumours. Carcinogenesis 27 (2006) 454-464
28. Jubb A.M., Zhong F., Bheddah S., Grabsch H.I., Frantz G.D., Mueller W., Kavi V., Quirke P., Polakis P., and Koeppen H. EphB2 is a prognostic factor in colorectal cancer. Clin. Cancer Res. 11 (2005) 5181-5187
29. Davalos V., Dopeso H., Castano J., Wilson A.J., Vilardell F., Romero-Gimenez J., Espin E., Armengol M., Capella G., Mariadason J.M., Aaltonen L.A., Schwartz Jr. S., and Arango D. EPHB4 and survival of colorectal cancer patients. Cancer Res. 66 (2006) 8943-8948
30. Huusko P., Ponciano-Jackson D., Wolf M., Kiefer J.A., Azorsa D.O., Tuzmen S., Weaver D., Robbins C., Moses T., Allinen M., Hautaniemi S., Chen Y., Elkahloun A., Basik M., Bova G.S., Bubendorf L., Lugli A., Sauter G., Schleutker J., Ozcelik H., Elowe S., Pawson T., Trent J.M., Carpten J.D., Kallioniemi O.P., and Mousses S. Nonsense-mediated decay microarray analysis identifies mutations of EPHB2 in human prostate cancer. Nat. Genet. 36 (2004) 979-983
31. Iiizumi M., Hosokawa M., Takehara A., Chung S., Nakamura T., Katagiri T., Eguchi H., Ohigashi H., Ishikawa O., Nakamura Y., and Nakagawa H. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth. Cancer Sci. 97 (2006) 1211-1216
32. Kim W.R., Kim Y., Eun B., Park O.H., Kim H., Kim K., Park C.H., Vinsant S., Oppenheim R.W., and Sun W. Impaired migration in the rostral migratory stream but spared olfactory function after the elimination of programmed cell death in Bax knock-out mice. J. Neurosci. 27 (2007) 14392-14403
33. Lindsten T., Golden J.A., Zong W.X., Minarcik J., Harris M.H., and Thompson C.B. The proapoptotic activities of Bax and Bak limit the size of the neural stem cell pool. J. Neurosci. 23 (2003) 11112-11119
34. Shi J., Parada L.F., and Kernie S.G. Bax limits adult neural stem cell persistence through caspase and IP3 receptor activation. Cell Death Differ. 12 (2005) 1601-1612